首页|单剂水痘疫苗策略下新生儿水痘的临床研究

单剂水痘疫苗策略下新生儿水痘的临床研究

扫码查看
目的 了解单剂水痘疫苗(VarV)策略时期新生儿水痘的流行病学、临床特征和治疗结局,为预防新生儿水痘提供相应依据。方法 收集2010年至2020年复旦大学附属儿科医院收治的新生儿水痘病例的临床资料,并进行回顾性临床病例系列研究。临床资料包括流行病学暴露、先发病家庭成员的VarV接种史、并发症、治疗结局、住院时间、住院费用等。统计学方法采用独立样本t检验和Spearman线性相关分析。结果 共收治125例新生儿水痘病例。90。4%(113/125)的新生儿水痘病例发病前有明确的患有水痘或带状疱疹家庭成员暴露史,其中94例为母亲。94例先发病母亲中有35例(37。2%)在儿童时期接种过1剂VarV,4例先发病兄弟姐妹都只接种过1剂VarV,4例先发病祖父母和1例保姆均未接种过VarV和带状疱疹疫苗。所有新生儿水痘病例在入院后即接受静脉输注阿昔洛韦治疗。有并发症新生儿水痘病例的住院时间为(4。9±2。0)d,长于无并发症病例的(4。1±1。2)d;住院费用为(5 739。9±3 868。2)元,高于无并发症病例的(4 047。0±1 556。0)元;差异均有统计学意义(t=2。18、2。34,均P<0。05)。所有新生儿水痘病例均存活。住院费用与发病至住院天数呈正相关(r=0。183,P=0。041)。母亲接种过1剂VarV的新生儿水痘病例组的住院费用为(3 857。9*899。0)元,少于未接种过VarV组的(4 673。8±2 228。6)元,差异有统计学意义(t=2。46,P=0。016)。结论 为预防新生儿水痘,建议适龄儿童完成2剂VarV,易感育龄期父母接种2剂VarV,50岁以上人群接种带状疱疹疫苗。
Clinical study of neonatal varicella under the single-dose varicella vaccine strategy
Objective To understand the epidemiological and clinical characteristics,and treatment outcomes of neonatal varicella during the era of the single-dose varicella vaccine(VarV)strategy in China,and to provide relevant evidence for the prevention of neonatal varicella.Methods The clinical data of neonatal varicella cases from 2010 to 2020 at the Children's Hospital of Fudan University were retrospectively collected.The clinical data included epidemiological exposure,vaccination history of family members,complications,treatment,outcomes,hospital stay and hospital cost.Independent sample t test and Spearman rank correlation coefficient were used for linear correlation analysis.Results A total of 125 neonatal varicella cases were treated.Among them,90.4%(113/125)had a clear history of exposure to a family member with varicella or herpes zoster before onset,with 94 cases involving the mother.Of the 94 mothers,35(37.2%)had received one dose of VarV during childhood,four siblings had also received one dose of VarV,and four grandparents and one nanny had not been vaccinated with either VarV or shingles vaccine.All neonatal varicella cases were treated with intravenous acyclovir upon admission.Neonatal varicella cases with complications had a longer hospital stay((4.9±2.0)days)and incurred higher hospital cost((5 739.9±3 868.2)yuan)compared to those without complications((4.1±1.2)days and(4 047.0±1 556.0)yuan,respectively).These differences were both statistically significant(t=2.18,2.34,respectively;both P<0.05).All neonatal varicella cases survived.There was a positive correlation between the hospital cost and the days from disease onset to hospitalization(r=0.183,P=0.041).The hospital cost in the group whose mothers had received one dose of VarV was lower compared to that in the group whose mother had not been vaccinated((3 857.9±899.0)yuan vs(4 673.8±2 228.6)yuan),with the difference statistically significant(t=2.46,P=0.016).Conclusions To prevent neonatal varicella,it is recommended that children of appropriate age complete two doses of VarV schedule,susceptible parents of reproductive age receive two doses of VarV,and individuals aged 50 years and older receive shingles vaccine.

Varicella zoster virus infectionInfant,newbornVaccinesPrevention

杨蕾、曾玫、朱燕凤

展开 >

复旦大学附属儿科医院感染科,上海 201102

水痘带状疱疹病毒感染 婴儿,新生 疫苗 预防

上海市第六轮加强公共卫生建设三年行动计划

GWVI-2.1.2

2024

中华传染病杂志
中华医学会

中华传染病杂志

CSTPCD北大核心
影响因子:0.791
ISSN:1000-6680
年,卷(期):2024.42(6)